The story of Viagra, formerly marketed by copyright, presents a complex case study for investors considering the pharmaceutical sector. Although its groundbreaking success and creation of vast in earnings , the patent expiration has opened the way for generic medications, significantly eroding profit opportunities. This change raises questions abou